Descriptor English: | Lisdexamfetamine Dimesylate | ||||
Descriptor Spanish: |
Dimesilato de Lisdexanfetamina
| ||||
Descriptor Portuguese: | Dimesilato de Lisdexanfetamina | ||||
Descriptor French: | Dimésylate de lisdexamfétamine | ||||
Entry term(s): |
Dimesylate, Lis-dexamfetamine Dimesylate, Lisdexamfetamine Elvanse Lis dexamfetamine Dimesylate Lis-dexamfetamine Dimesylate Lisdexamfetamine NRP 104 NRP-104 NRP104 Vyvanse |
||||
Tree number(s): |
D02.092.471.683.152.110.200.500 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069478 | ||||
Scope note: | A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Central Nervous System Stimulants Dopamine Uptake Inhibitors |
||||
Registry Number: | SJT761GEGS | ||||
Public MeSH Note: | 2016; LISDEXAMFETAMINE DIMESYLATE was indexed under DEXTROAMPHETAMINE 2006-2015 |
||||
History Note: | 2016 (2006) |
||||
DeCS ID: | 55880 | ||||
Unique ID: | D000069478 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2016/01/01 | ||||
Date of Entry: | 2015/07/01 | ||||
Revision Date: | 2015/06/26 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Lisdexamfetamine Dimesylate
- Preferred
Vyvanse
- Narrower
Elvanse
- Narrower
Lisdexamfetamine
- Broader
NRP104
- Narrower
Concept UI |
M0502623 |
Scope note | A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER. |
Preferred term | Lisdexamfetamine Dimesylate |
Entry term(s) |
Dimesylate, Lis-dexamfetamine Dimesylate, Lisdexamfetamine Lis dexamfetamine Dimesylate Lis-dexamfetamine Dimesylate |
Concept UI |
M0506857 |
Preferred term | Vyvanse |
Concept UI |
M0592770 |
Preferred term | Elvanse |
Concept UI |
M0583181 |
Preferred term | Lisdexamfetamine |
Concept UI |
M0502624 |
Preferred term | NRP104 |
Entry term(s) |
NRP 104 NRP-104 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey